Insights

Expanding Product Line Ncardia has recently launched a panel of ready-to-use assays and a comprehensive drug discovery platform for obstructive hypertrophic cardiomyopathy, presenting opportunities to promote these new offerings to biopharmaceutical companies looking for innovative solutions in drug discovery.

New Business Venture The launch of Cellistic, a cell therapy manufacturing business by Ncardia, provides a potential avenue for sales partnerships or collaborations for organizations in the biotechnology and pharmaceutical industry seeking to optimize their iPSC-related process development and production capabilities.

Strategic Partnerships Ncardia's strategic partnership with Kiniciti and hiring of Andy Holt as Chief Commercial Officer signify opportunities for sales professionals to explore collaborations, licensing agreements, or joint ventures with Ncardia to leverage their expertise in stem cell-based solutions for drug discovery.

Financing for Growth The recent financing of over $60 million secured by Ncardia through strategic partnerships with investors like Kiniciti highlights the company's financial stability and growth potential, making it an attractive partner for businesses looking to invest or engage in joint ventures within the biotechnology research sector.

Innovative Product Offerings With revenue in the range of $10-50 million, Ncardia's focus on leveraging iPSC technology for novel therapies and drug discovery presents an opportunity for sales professionals to engage biopharmaceutical companies interested in cutting-edge stem cell technologies for advancing their research and development pipelines.

Similar companies to Ncardia

Ncardia Tech Stack

Ncardia uses 8 technology products and services including Matomo, Shopify, Vue.js, and more. Explore Ncardia's tech stack below.

  • Matomo
    Analytics
  • Shopify
    E-commerce
  • Vue.js
    Javascript Frameworks
  • Intercom
    Live Chat
  • Envoy
    Load Balancers
  • HubSpot
    Marketing Automation
  • KVM
    Virtualisation Software
  • Twitter
    Widgets

Media & News

Ncardia's Email Address Formats

Ncardia uses at least 1 format(s):
Ncardia Email FormatsExamplePercentage
First.Last@ncardia.comJohn.Doe@ncardia.com
89%
First.MiddleLast@ncardia.comJohn.MichaelDoe@ncardia.com
8%
FirLast@ncardia.comJohDoe@ncardia.com
2%
First@ncardia.comJohn@ncardia.com
1%

Frequently Asked Questions

Where is Ncardia's headquarters located?

Minus sign iconPlus sign icon
Ncardia's main headquarters is located at Ncardia Leiden, Galileiweg 8 Building BioPartner 1 Leiden, South Holland 2333 BD NL. The company has employees across 2 continents, including EuropeNorth America.

What is Ncardia's official website and social media links?

Minus sign iconPlus sign icon
Ncardia's official website is ncardia.com and has social profiles on LinkedIn.

How much revenue does Ncardia generate?

Minus sign iconPlus sign icon
As of January 2025, Ncardia's annual revenue reached $35M.

What is Ncardia's SIC code NAICS code?

Minus sign iconPlus sign icon
Ncardia's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Ncardia have currently?

Minus sign iconPlus sign icon
As of January 2025, Ncardia has approximately 58 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: G. M.CSO: H. B.Chief People Officer: V. D.. Explore Ncardia's employee directory with LeadIQ.

What industry does Ncardia belong to?

Minus sign iconPlus sign icon
Ncardia operates in the Biotechnology Research industry.

What technology does Ncardia use?

Minus sign iconPlus sign icon
Ncardia's tech stack includes MatomoShopifyVue.jsIntercomEnvoyHubSpotKVMTwitter.

What is Ncardia's email format?

Minus sign iconPlus sign icon
Ncardia's email format typically follows the pattern of . Find more Ncardia email formats with LeadIQ.

How much funding has Ncardia raised to date?

Minus sign iconPlus sign icon
As of January 2025, Ncardia has raised $60M in funding. .

When was Ncardia founded?

Minus sign iconPlus sign icon
Ncardia was founded in 2011.
Ncardia

Ncardia

Biotechnology ResearchSouth Holland, Netherlands51-200 Employees

Ncardia is a drug discovery company and expert in human iPSC technology. We operate worldwide with facilities, offices and staff throughout Europe and North America. We work with biopharmaceutical companies in drug discovery worldwide, to leverage the power of stem cell technologies in the development of novel therapies of multiple modalities at any stage of development. 

Over the past 10 years, we have built the expertise and infrastructure required to differentiate, manufacture and characterize high-quality iPSC-derived cell and disease models. We can facilitate the process of disease modeling and high-throughput screening to accelerate drug discovery.
We listen to our customer’s project plans, questions and challenges, and co-develop human iPSC-based solutions that fit their specifications.

Explore our website to learn more www.ncardia.com.

Section iconCompany Overview

Headquarters
Ncardia Leiden, Galileiweg 8 Building BioPartner 1 Leiden, South Holland 2333 BD NL
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
51-200

Section iconFunding & Financials

  • $60M

    Ncardia has raised a total of $60M of funding over 1 rounds. .

  • $10M$50M

    Ncardia's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $60M

    Ncardia has raised a total of $60M of funding over 1 rounds. .

  • $10M$50M

    Ncardia's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.